CNX’s CEO Guy Clark nominated as finalist for ‘CEO of the Year’ award!

We are delighted to announce that our CEO Guy Clark has been nominated as a finalist for ‘CEO of the Year’ at this year’s CPHI Pharma Awards.

The CPHI Pharma Awards are hosted annually and aim to recognise excellence and innovation in the pharmaceutical industry.

The nomination is testament to Guy’s transformational leadership. He joined as CEO in January 2022, and since then the company has grown significantly. In just over a year, CNX has transitioned from having one product to twenty, partners in less than 10 markets to almost 50, and we have sales forecast to more than treble next year.

When asked about the recognition for his efforts, Guy said; “A bit like football Manager of the Month awards, it comes down to what the players are doing on the pitch … Our amazing team have worked so hard to get us where we are aiming to go, and continue to embrace new challenges and opportunities.”

The winner will be announced at the awards ceremony on 24^th October in Barcelona – good luck Guy!